在子宫内膜异位症患者中易怒肠综合征的患病率:一个横截面研究
Nashwa Aldardier1, Ghaida A Eissa2, Abdulaziz M Shaheen2
1Department of Obstertrics and Gynecology, King Abdulaziz University, Jeddah, Saudi Arabia.
相当数量的子宫内膜异位症患者也患有刺激性肠综合征 (IBS). 这项研究强调了医疗保健提供者需要将IBS视为子宫内膜异位症患者的潜在并发症,特别是在沙特阿拉伯.
科学领域:
- 胃肠病学 胃肠病学
- 妇科 妇科 妇科 妇科
- 流行病学 流行病学
背景情况:
- 刺激性肠综合征 (IBS) 和子宫内膜异位症之间的相关性存在有限的研究,特别是在沙特阿拉伯.
- 子宫内膜异位症是一种普遍的疾病,但它与IBS的同时发生仍然未得到充分探索.
- 这项研究解决了沙特阿拉伯背景下对子宫内膜异位症患者IBS患病率的知识差距.
研究的目的:
- 在被诊断为子宫内膜异位症的患者中调查刺激性肠综合征 (IBS) 的患病率.
- 确定与IBS和子宫内膜异位症同时发生相关的潜在风险因素.
- 为了在特定的地理区域中更清楚地理解这两种条件之间的关系.
主要方法:
- 在吉达的阿卜杜勒阿齐兹国王大学医院进行了一项横截面研究.
- 数据收集时间为2023年9月至12月.
- 参与者包括18岁及以上的女性,其子宫内膜异位症诊断已确认.
主要成果:
- 在研究的子宫内膜异位症患者中,近一半 (47.8%) 患者先前有IBS诊断.
- 与非沙特患者相比,沙特患者的IBS患病率明显高.
- 虽然人口统计学和子宫内膜异位症因素没有显著联系,但慢性消化问题,如食物不耐受性增加了IBS的可能性.
结论:
- 刺激性肠综合征 (IBS) 和子宫内膜异位症之间存在着相当大的关联.
- 医疗保健提供者应将IBS视为子宫内膜异位症患者潜在的并发症.
- 建议进行进一步的研究,以探索潜在的机制,并优化双重诊断的管理策略.
更多相关视频
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
08:13Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
Published on: April 5, 2024
相关概念视频
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS
